Evidence map›Paper›PMID 36263611›Full record

ArticleMolecular medicine reports2022

Lipocalin 2 activates the NLRP3 inflammasome via LPS‑induced NF‑κB signaling and plays a role as a pro‑inflammatory regulator in murine macrophages.

Se Lim Kim, Min Woo Shin, Sang Wook Kim

Abstract read
In one paragraph

Article in Molecular medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Se Lim KimDepartment of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, Jeonbuk 54907, Republic of Korea.
Min Woo ShinDepartment of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, Jeonbuk 54907, Republic of Korea.
Sang Wook KimDepartment of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, Jeonbuk 54907, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipocalin 2 (LCN2) is highly expressed in several infectious and inflammatory disorders. However, the expression level and underlying mechanism of LCN2 in inflammatory bowel disease (IBD) are poorly understood. The current study used murine IBD models and LPS‑activated macrophages to elucidate the role of LCN2 in IBD pathogenesis. The levels of LCN2 protein and concentration were confirmed to be much higher in the colons of colitis‑induced mice compared with healthy mice using immunohistochemistry, western blotting and ELISA assay.

Indexed as

InflammasomesInflammatory Bowel DiseasesAnimalsCaspasesLipocalin-2LipopolysaccharidesMacrophagesMiceMice, Inbred NODNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinCaspasesInflammasomesLipocalin-2LipopolysaccharidesNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseIL‑1βinflammasomeinflammationinflammatory bowel diseaselipocalin 2lipopolysaccharideNF‑ĸBNOD‑ LRR‑ and pyrin domain‑containing protein 3

Identifiers

PMID36263611
PMCPMC9608086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.